309 related articles for article (PubMed ID: 31910043)
1. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
2. Dose Range Finding Studies with Two
Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
[TBL] [Abstract][Full Text] [Related]
5. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
[TBL] [Abstract][Full Text] [Related]
6. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
[TBL] [Abstract][Full Text] [Related]
7. Development of a Molecularly Stable Gene Therapy Vector for the Treatment of
Giacalone JC; Andorf JL; Zhang Q; Burnight ER; Ochoa D; Reutzel AJ; Collins MM; Sheffield VC; Mullins RF; Han IC; Stone EM; Tucker BA
Hum Gene Ther; 2019 Aug; 30(8):967-974. PubMed ID: 31106594
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
[TBL] [Abstract][Full Text] [Related]
9. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
[TBL] [Abstract][Full Text] [Related]
10. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
[TBL] [Abstract][Full Text] [Related]
11. Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
Martinez-Fernandez de la Camara C; Cehajic-Kapetanovic J; MacLaren RE
Expert Opin Emerg Drugs; 2022 Dec; 27(4):431-443. PubMed ID: 36562395
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
[TBL] [Abstract][Full Text] [Related]
13. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa.
Churchill JD; Bowne SJ; Sullivan LS; Lewis RA; Wheaton DK; Birch DG; Branham KE; Heckenlively JR; Daiger SP
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1411-6. PubMed ID: 23372056
[TBL] [Abstract][Full Text] [Related]
15. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
[TBL] [Abstract][Full Text] [Related]
16. Multiprotein complexes of Retinitis Pigmentosa GTPase regulator (RPGR), a ciliary protein mutated in X-linked Retinitis Pigmentosa (XLRP).
Murga-Zamalloa C; Swaroop A; Khanna H
Adv Exp Med Biol; 2010; 664():105-14. PubMed ID: 20238008
[TBL] [Abstract][Full Text] [Related]
17. X-linked retinitis pigmentosa in two families with a missense mutation in the RPGR gene and putative change of glycine to valine at codon 60.
Fishman GA; Grover S; Jacobson SG; Alexander KR; Derlacki DJ; Wu W; Buraczynska M; Swaroop A
Ophthalmology; 1998 Dec; 105(12):2286-96. PubMed ID: 9855162
[TBL] [Abstract][Full Text] [Related]
18. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa.
Pawlyk BS; Bulgakov OV; Sun X; Adamian M; Shu X; Smith AJ; Berson EL; Ali RR; Khani S; Wright AF; Sandberg MA; Li T
Gene Ther; 2016 Feb; 23(2):196-204. PubMed ID: 26348595
[TBL] [Abstract][Full Text] [Related]
19. Molecular Strategies for RPGR Gene Therapy.
Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940
[TBL] [Abstract][Full Text] [Related]
20. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.
Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
